IEEE Trans Biomed Eng. 2018 Mar;65(3):575-586. doi: 10.1109/TBME.2017.2707344. Epub 2017 May 23.
The development of artificial pancreas (AP) technology for deployment in low-energy, embedded devices is contingent upon selecting an efficient control algorithm for regulating glucose in people with type 1 diabetes mellitus. In this paper, we aim to lower the energy consumption of the AP by reducing controller updates, that is, the number of times the decision-making algorithm is invoked to compute an appropriate insulin dose.
Physiological insights into glucose management are leveraged to design an event-triggered model predictive controller (MPC) that operates efficiently, without compromising patient safety. The proposed event-triggered MPC is deployed on a wearable platform. Its robustness to latent hypoglycemia, model mismatch, and meal misinformation is tested, with and without meal announcement, on the full version of the US-FDA accepted UVA/Padova metabolic simulator.
The event-based controller remains on for 18 h of 41 h in closed loop with unannounced meals, while maintaining glucose in 70-180 mg/dL for 25 h, compared to 27 h for a standard MPC controller. With meal announcement, the time in 70-180 mg/dL is almost identical, with the controller operating a mere 25.88% of the time in comparison with a standard MPC.
A novel control architecture for AP systems enables safe glycemic regulation with reduced processor computations.
Our proposed framework integrated seamlessly with a wide variety of popular MPC variants reported in AP research, customizes tradeoff between glycemic regulation and efficacy according to prior design specifications, and eliminates judicious prior selection of controller sampling times.
开发可在低能量嵌入式设备中使用的人工胰腺 (AP) 技术,这取决于为 1 型糖尿病患者调节血糖选择一种高效的控制算法。本文旨在通过减少控制器更新来降低 AP 的能耗,即调用决策算法计算适当胰岛素剂量的次数。
利用对血糖管理的生理洞察来设计事件触发型模型预测控制器 (MPC),该控制器可以高效运行,同时不影响患者安全。所提出的事件触发型 MPC 部署在可穿戴平台上。在完整的美国 FDA 认可的 UVA/Padova 代谢模拟器上,测试了在没有和有餐食预告的情况下,该控制器对潜在低血糖、模型失配和餐食信息错误的鲁棒性。
在没有预告的餐食情况下,基于事件的控制器在闭环状态下运行 18 小时,有 25 小时的血糖保持在 70-180mg/dL,而标准 MPC 控制器则为 27 小时。有餐食预告时,控制器的运行时间几乎相同,与标准 MPC 相比,仅运行 25.88%的时间。
AP 系统的新型控制架构能够实现安全的血糖调节,同时减少处理器计算。
我们提出的框架与 AP 研究中报告的各种流行的 MPC 变体无缝集成,根据先前的设计规范定制血糖调节和效果之间的权衡,并且消除了对控制器采样时间的明智预先选择。